• SENSEX 82,726.64
    539.83 (+0.66%)
  • BANKNIFTY 57,210.45
    454.45 (+0.80%)
  • Oberoi Realty
    1,751.00 1,440.05(%)
  • Canara Bank
    106.35 78.58(%)
  • SpiceJet
    40.84 79.90(%)
  • Lodha Developers
    1,330.55 1,036.00(%)
  • Havells India
    1,549.05 1,360.05(%)
  • ICICI Bank
    1,489.95 1,489.95(%)
  • One 97
    1,090.00 1,090.00(%)
  • Bombay Dyeing
    190.85 256.25(%)
  • Ola Electric
    43.95 157.53(%)
  • Dixon Technolog.
    16,671.15 19,149.80(%)
  • Anthem Bioscienc
    765.00 765.00(%)
  • Eternal Ltd
    303.60 311.60(%)
  • Paradeep Phosph.
    205.60 205.60(%)
  • Pidilite Inds.
    2,900.75 2,620.15(%)
  • Reliance Industr
    1,426.90 1,551.00(%)
  • I R F C
    136.90 208.95(%)
  • Monika Alcobev
    289.95 289.95(%)
  • St Bk of India
    825.00 889.00(%)
  • Waaree Energies
    3,199.00 3,740.75(%)
  • Jayaswal Neco
    43.10 55.34(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Coral Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Coral
  • BSE Code : 3676.0
  • ISIN : INE683E01017
575.70 4 (0.78%)
  • As on 23 Jul 2025 (EOD)

  • Today’s Low

    570.00

  • Today’s High

    587.00

  • Open

    575.00

  • Perv Close

    571.25

  • 52W Low

    560.70

  • 52W High

    999.00

Key Indicators

  • P/E(TTM)

    8.31

  • Mar.Cap (₹Cr.)

    205.52

  • Div & Yield %

    0.00

  • Book Value(₹)

    563.59

  • Debt-Equity Ratio

    0.78

  • AGM Date

    23-Jul-2025

  • EPS

    69.27

  • P/E Ratio

    8.31

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    205.52

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    3.57

  • BV (₹)

    563.60

  • Sales( ₹ in Cr.)

    115.01

  • NP (in Cr.)

    24.73

  • NP Var(%)

    55.0

  • Div%

    0.0

  • CPS (₹)

    74.90

  • EPS (₹)

    69.30

  • Traded Value (₹ in Lakhs)

    205.52

  • 52 Week High

    999.00

  • 52 Week Low

    560.70

  • Price BSE

    576.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    205.52

  • P/C Ratio

    7.70

  • P/E Ratio

    8.30

  • Price Vs.BV

    69.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 83.66 78.12 75.61 96.57 70.58 91.08
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 83.66 78.12 75.61 96.57 70.58 91.08
Other Income 6.63 6.93 5.77 3.79 5.89 5.16
Stock Adjustments 3.13 -3.64 -0.71 0.05 2.94 -0.01
Total Income 93.42 81.41 80.67 100.41 79.41 96.23
EXPENDITURE :            
Raw Materials 40.38 42.11 39.01 50.11 42.97 50.76
Power and Fuel Cost 3.05 3.10 2.55 2.05 1.82 1.85
Employee Cost 11.20 11.13 11.23 10.18 9.70 9.84
Other Manufacturing Expenses 3.96 4.55 4.01 5.81 4.64 7.27
Selling and Administration Expenses 8.39 9.55 9.61 9.32 6.45 6.53
Miscellaneous Expenses 3.74 0.23 0.28 3.29 2.52 2.40
Employee Benefit Expenses 11.20 11.13 11.23 10.18 9.70 9.84
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 70.72 70.68 66.69 80.76 68.10 78.65
Operating Profit 22.71 10.75 13.99 19.64 11.31 17.58
Interest 0.00 0.34 0.14 0.04 0.19 0.17
Gross Profit 22.71 10.41 13.85 19.60 11.12 17.41
Depreciation 1.98 2.18 1.99 1.98 2.01 1.90
Profit Before Tax 20.73 8.23 11.86 17.62 9.11 15.51
Current Tax 4.91 1.82 2.75 4.50 2.50 5.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.03 -0.04 0.06 -0.44 -0.51 0.29
Reported Net Profit 15.79 6.45 9.05 13.55 7.13 10.22
Extraordinary Items -0.12 0.03 0.73 0.01 0.00 0.00
Adjusted Net Profit 15.91 6.42 8.32 13.54 7.13 10.22
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -4.37 -11.92
P & L Balance brought forward 131.67 125.23 116.18 102.63 105.99 108.56
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.86 0.86
P & L Balance carried down 147.46 131.67 125.23 116.18 107.89 105.99
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 20.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 2.00
Earnings Per Share-Unit Curr 44.19 18.04 25.32 37.94 19.96 28.60
Earnings Per Share(Adj)-Unit Curr 44.19 18.04 25.32 37.94 19.96 28.60
Book Value 496.83 433.29 436.81 382.48 323.77 318.45
Book Value(Adj)-Unit Curr 496.83 433.29 436.81 382.48 323.77 318.45

Shareholding Pattern

  • Promoter Group

    71.51%

  • Public Share Holding

    28.49%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 1,841,453 1,841,453.00 1,841,453 1,841,453
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 1,841,453 51.54 1,841,453 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 713,351 19.97 713,351 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 713,351 19.97 713,351 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 47,742 1.34 47,442 37
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 101,047 2.83 97,047 120
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 37,380 1.05 37,380 140
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 120,268 3.37 120,268 3
Individuals holding nominal share capital up to Rs. 1 lakh 621,582 17.40 571,641 3,906
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 88,917 2.49 88,917 1
Sub Total 1,017,796 28.49 963,555 4,211
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,572,600 100.00 3,518,359 4,213

Company Background

Coral Laboratories LtdPharmaceuticals - Indian - Formulations

  • Coral Laboratories Ltd
  • BSE Code : 3676.0
  • ISIN : INE683E01017

  • Incorporation Year

    1981

  • Registered Office

    SF-206 Silver Oak Complex
    BPC Road, Vadodara,
    Gujarat-390020

  • Telephone

    91-022-2500 5245/46

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Dhwani Desai

  • Auditor

    M A Parekh & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Coral Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Coral Labs. 575.70 90.29 83.66 8.51 12.26
Abbott India 34,745.50 6,684.73 6,409.15 52.20 44.95
Astrazeneca Phar 8,953.35 1,330.33 1,295.53 193.38 33.26
P & G Health Ltd 5,920.55 1,166.89 1,151.26 39.13 39.76
Glaxosmi. Pharma 3,130.55 3,866.05 3,723.49 57.71 58.72
Cipla 1,473.35 20,029.57 19,044.85 23.08 21.40
Amrutanjan Healt 692.60 437.58 421.23 39.40 20.84
Fermenta Biotec. 379.25 442.21 430.53 16.51 17.61
Guj. Themis Bio. 372.55 174.19 169.82 83.16 44.82
Bliss GVS Pharma 156.90 703.42 667.20 23.99 9.16
Ambalal Sarabhai 34.60 19.33 4.04 32.04 2.10